Cite
HARVARD Citation
Hashim, Y. et al. (2017). The Targeted SMAC Mimetic SW IV-134 is a strong enhancer of standard chemotherapy in pancreatic cancer. Journal of experimental & clinical cancer research. 36 (1), pp. 1-10. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Hashim, Y. et al. (2017). The Targeted SMAC Mimetic SW IV-134 is a strong enhancer of standard chemotherapy in pancreatic cancer. Journal of experimental & clinical cancer research. 36 (1), pp. 1-10. [Online].